Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

被引:12
作者
Shi, Zhenguo [1 ,2 ]
Zhu, Xiaojuan [2 ]
Ke, Shaobo [1 ]
Qiu, Hu [1 ]
Cai, Gaoke [1 ]
Zhangcai, Yutian [1 ]
Chen, Yongshun [1 ]
机构
[1] Wuhan Univ, Dept Clin Oncol, Renmin Hosp, Wuhan, Peoples R China
[2] Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Elderly patients; Synchronous oligometastatic esophageal; squamous cell carcinoma; Concurrent chemoradiotherapy; Survival; Nomogram; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMORADIOTHERAPY; RADIATION-THERAPY; CANCER; RADIOTHERAPY; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; OUTCOMES; DISEASE;
D O I
10.1016/j.radonc.2021.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to establish a nomogram for predicting survival outcomes of elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOEC). Materials and methods: This study eventually enrolled 314 elderly patients who initially diagnosed with SOEC from two centers. Treatment responses and outcomes of 151 patients receiving CCRT and 163 patients undergoing chemotherapy alone (CT) were compared. Propensity score matching and landmark analyses were performed to control potential confounding factors. A nomogram was established on the basis of the Cox regression model. Results: After a median follow-up of 42.3 months, CCRT was superior to CT alone in objective response rate (ORR, 59.6% vs. 39.9%, P < 0.001), median progression-free survival (PFS, 10.0 vs. 7.2 months, P < 0.001), and median overall survival (OS, 18.5 vs. 15.6 months, P < 0.001). The propensity score matching (PSM) and landmark analyses redemonstrated the same trend (P < 0.01). On hierarchical analysis, patients with 1- 3 metastatic lesions involving one organ displayed longer median PFS (9.0 vs. 7.8 months, P = 0.008) and OS (17.8 vs. 15.2 months, P < 0.001) than those with 4-5 metastatic lesions involving 2-3 organs. The major toxicities of grade III or higher for CCRT included leukocytopenia (23.2%), radiation esophagitis (7.3%), and radiation pneumonitis (8.6%). Cox multivariate analysis showed that the number of metastatic lesions (P = 0.012) and tumor response (P < 0.001) were independent prognostic factors associated with OS. A nomogram was established by incorporating the number of metastatic lesions and tumor response, with a concordance index of 0.743 after internal cross-validation. Calibration curves and decision curve analysis confirmed that nomogram had a favorable predictive value for individualized survival. Conclusions: Compared with CT alone, CCRT exhibited superior efficacy and acceptable toxicity in the first line treatment for elderly patients with SOEC. The current study supports the oligometastatic definition of <3 metastatic lesions involving one organ for esophageal cancer patients. The constructed nomogram can effectively predict the individualized survival. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 236-244
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [41] The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
    Deng, Xuyang
    He, Wenwu
    Jiang, Yingchun
    Deng, Sijie
    Mao, Tianqin
    Leng, Xuefeng
    Luo, Qiyu
    Zheng, Kai
    Han, Yongtao
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [42] Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis
    Li, Chia-Chin
    Chen, Chih-Yi
    Chien, Chun-Ru
    [J]. ONCOTARGET, 2016, 7 (44) : 71548 - 71555
  • [43] A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma
    Tang, Hua-Rong
    Ma, Hai-Feng
    An, Shi-Min
    Badakhshi, Harun
    Deng, Jia-Ying
    Zhang, Jun-Hua
    Chen, Yun
    Zhang, Zhen
    Guo, Xiao-Mao
    Jiang, Guo-Liang
    Zhao, Kuai-Le
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 350 - 354
  • [44] Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
    Xie, Renxian
    Cai, Qingxin
    Chen, Tong
    Huang, Hongxin
    Chen, Chuangzhen
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Effectiveness of Esophagectomy in Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Definitive Radiotherapy or Concurrent Chemoradiotherapy Through Intensity-Modulated Radiation Therapy Techniques
    Yen, Yu-Chun
    Chang, Jer-Hwa
    Lin, Wei-Cheng
    Chiou, Jeng-Fong
    Chang, Yin-Chun
    Chang, Chia-Lun
    Hsu, Han-Lin
    Chow, Jyh-Ming
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    [J]. CANCER, 2017, 123 (11) : 2043 - 2053
  • [46] Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma
    Ono, Takashi
    Wada, Hitoshi
    Ishikawa, Hitoshi
    Tamamura, Hiroyasu
    Tokumaru, Sunao
    [J]. THORACIC CANCER, 2020, 11 (08) : 2170 - 2177
  • [47] Concurrent Chemoradiotherapy in Elderly Patients with Locally Advanced Esophageal Carcinoma
    Jung, Bae Kwon
    Kang, Ki Mun
    Lee, Gyeong Won
    Kang, Jung Hoon
    Kim, Hoon Gu
    Lee, Won Seob
    Chai, Gyu Young
    [J]. RADIATION ONCOLOGY JOURNAL, 2009, 27 (02): : 84 - 90
  • [48] Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study
    Lin, Chen-Yuan
    Lien, Ming-Yu
    Chen, Chi-Ching
    Fang, Hsin-Yuan
    Lin, Yu-Sen
    Chen, Chien-Kuang
    Chen, Jian-Xun
    Lu, Ting-Yu
    Huang, Tzu-Min
    Hsieh, Te-Chun
    Sun, Shung-Shung
    Li, Chia-Chin
    Chien, Chun-Ru
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [49] Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis
    Li, Kexun
    Li, Changding
    Nie, Xin
    He, Wenwu
    Du, Kunyi
    Liu, Kun
    Wang, Chenghao
    Li, Jialong
    Han, Yongtao
    Peng, Lin
    Wang, Qifeng
    Leng, Xuefeng
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (05) : 611 - 620
  • [50] Predicting the risk of interval distant metastases in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy
    Lin, Yong-Jhih
    Chang, Yu-Chuan
    Wen, Yu-Wen
    Chan, Sheng-Chieh
    Chao, Yin-Kai
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (02) : 539 - 545